Takuya Fukunaga

New cyclic tetrapeptides from Nonomuraea sp. TA-0426 that inhibit glycine transporter type 1 (GlyT1).

Y. Chu, Y. Toda, Y. Terui, 2008, Bioorganic & medicinal chemistry letters.

New cyclic tetrapeptides from Nonomuraea sp. TA-0426 that inhibit glycine transporter type 1 (GlyT1).

Y. Chu, Y. Toda, Y. Terui, 2008, Bioorganic & medicinal chemistry letters.

Lead identification of novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent heparanase-1 inhibitor.

Sayaka Kato, H. Kakinuma, Sota Kato, 2022, Bioorganic & medicinal chemistry letters.

Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition.

H. Kakinuma, Hiroko Koretsune, Yuji Ito, 2022, Journal of medicinal chemistry.

Discovery of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent and selective heparanase-1 inhibitor utilizing an improved synthetic approach.

H. Kakinuma, Takuya Fukunaga, R. Tabata, 2023, Bioorganic & medicinal chemistry letters.

Structure-based lead optimization to improve potency and selectivity of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid series of heparanase-1 inhibitor.

H. Kakinuma, H. Miyagawa, Mayumi Endo, 2023, Bioorganic & medicinal chemistry.

Discovery of novel indole derivatives as potent and selective inhibitors of proMMP-9 activation.

Mayumi Endo, T. Asami, C. Mishima-Tsumagari, 2023, Bioorganic & medicinal chemistry letters.